[go: up one dir, main page]

NO822391L - Karbostyrilforbindelser, preparater inneholdende disse og fremgangsmaater for fremstilling av forbindelsene - Google Patents

Karbostyrilforbindelser, preparater inneholdende disse og fremgangsmaater for fremstilling av forbindelsene

Info

Publication number
NO822391L
NO822391L NO822391A NO822391A NO822391L NO 822391 L NO822391 L NO 822391L NO 822391 A NO822391 A NO 822391A NO 822391 A NO822391 A NO 822391A NO 822391 L NO822391 L NO 822391L
Authority
NO
Norway
Prior art keywords
compounds
carbostyral
procedures
preparing
preparations containing
Prior art date
Application number
NO822391A
Other languages
English (en)
Other versions
NO157819C (no
NO157819B (no
Inventor
Tominanga Michiaki
Yang Yung-Hsiung
Ogawa Hidenori
Nakagawa Kazuyuki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP55159016A external-priority patent/JPS5782390A/ja
Priority claimed from JP55179950A external-priority patent/JPS57102888A/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of NO822391L publication Critical patent/NO822391L/no
Publication of NO157819B publication Critical patent/NO157819B/no
Publication of NO157819C publication Critical patent/NO157819C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • C07D215/28Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • C07D215/32Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO82822391A 1980-11-11 1982-07-09 Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo (1,2-a)-pyridin-2-yl-karbostyrilforbindelser. NO157819C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP55159016A JPS5782390A (en) 1980-11-11 1980-11-11 Carbostyril derivative
JP55179950A JPS57102888A (en) 1980-12-18 1980-12-18 Carbostyril derivative
PCT/JP1981/000328 WO1982001706A1 (en) 1980-11-11 1981-11-11 Carbostyril compounds,composition containing same,and process for their preparation

Publications (3)

Publication Number Publication Date
NO822391L true NO822391L (no) 1982-07-09
NO157819B NO157819B (no) 1988-02-15
NO157819C NO157819C (no) 1988-05-25

Family

ID=26485945

Family Applications (1)

Application Number Title Priority Date Filing Date
NO82822391A NO157819C (no) 1980-11-11 1982-07-09 Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo (1,2-a)-pyridin-2-yl-karbostyrilforbindelser.

Country Status (19)

Country Link
US (1) US4414390A (no)
EP (1) EP0052016B1 (no)
KR (1) KR880001657B1 (no)
AT (1) AT382376B (no)
AU (1) AU547586B2 (no)
CA (1) CA1164459A (no)
CH (1) CH653684A5 (no)
DE (1) DE3152512T1 (no)
DK (1) DK157193C (no)
ES (1) ES507545A0 (no)
FI (1) FI71145C (no)
IT (1) IT8149680A0 (no)
MX (1) MX6802E (no)
NO (1) NO157819C (no)
PH (1) PH17158A (no)
PT (1) PT73959B (no)
SE (1) SE440653B (no)
SU (1) SU1215621A3 (no)
WO (1) WO1982001706A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537889A (en) * 1982-12-27 1985-08-27 Eli Lilly And Company Inotropic agents
US4636502A (en) * 1982-12-27 1987-01-13 Eli Lilly And Company Methods of producing a positive inotropic effect or vasodilation by administration of 2-phenyl imidazo pyrimidines and pyrazines
GB8305245D0 (en) * 1983-02-25 1983-03-30 Fujisawa Pharmaceutical Co Imidazo-heterocyclic compounds
US4533734A (en) * 1983-11-10 1985-08-06 Eli Lilly And Company Inotropic agents
US4710507A (en) * 1983-12-22 1987-12-01 Pfizer Inc. Quinolone inotropic agents
ES8608874A1 (es) * 1984-05-29 1986-09-01 Pfizer Un procedimiento para la preparacion de una 2-(1h)-quinolona
US4721721A (en) * 1984-12-18 1988-01-26 Rorer Pharmaceutical Corporation 6-(4-thiazole) compounds, cardiotonic compositions including the same, and their uses
FR2580646A1 (fr) * 1985-04-19 1986-10-24 Synthelabo Derives de 2(1h)-quinolinone, leur preparation et leur application en therapeutique
US4666913A (en) * 1985-11-22 1987-05-19 William H. Rorer, Inc. Hydroxy and aminothiazolyl-benzodiazinone compounds, cardiotonic compositions including the same, and their uses
GB8529362D0 (en) * 1985-11-28 1986-01-02 Pfizer Ltd Quinolone cardiac stimulants
GB8619902D0 (en) * 1986-08-15 1986-09-24 Pfizer Ltd Quinolone cardiac stimulants
GB8709448D0 (en) * 1987-04-21 1987-05-28 Pfizer Ltd Heterobicyclic quinoline derivatives
AU2682695A (en) * 1994-06-20 1996-01-15 Takeda Chemical Industries Ltd. Condensed imidazole compounds, their production and use
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
DE10117184A1 (de) * 2001-04-05 2002-10-17 Gruenenthal Gmbh Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen
DE10247271A1 (de) * 2002-10-10 2004-08-26 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yle
TWI324151B (en) * 2003-04-02 2010-05-01 Novartis Ag Process for the preparation of 5-(haloacetyl)-8-substituted oxy-(1h)-quinolin-2-ones
DE102005019181A1 (de) * 2005-04-25 2006-10-26 Novartis Ag Peptid-Deformylase (PDF) Inhibitoren 1
CN102216298B (zh) 2008-09-16 2014-04-16 Csir公司 作为hiv-1逆转录酶抑制剂的咪唑并吡啶和咪唑并嘧啶
ES2362894B1 (es) * 2009-11-16 2012-05-21 Ferrer Internacional S.A. Procedimiento de preparación del �?cido 4-nitro-oxi-metil-benzoico.
EP3280716B1 (de) * 2015-04-08 2020-02-12 Bayer CropScience AG Imidazo[1,2-a]pyridin-2-yl-derivate als schädlingsbekämpfungsmittel und deren zwischenprodukte
WO2017019828A1 (en) 2015-07-30 2017-02-02 Bristol-Myers Squibb Company Aryl substituted bicyclic heteroaryl compounds
JP6903732B2 (ja) 2016-07-14 2021-07-14 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company Par4阻害剤としての三環式ヘテロアリール置換のキノリンおよびアザキノリン化合物
JP7058256B2 (ja) * 2016-07-14 2022-04-21 ブリストル-マイヤーズ スクイブ カンパニー 二環式ヘテロアリール置換化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473819A (en) * 1976-01-28 1977-05-18 Gallardo Antonio Sa Derivatives of imidazo 1,2-a pyridine
ES8100015A1 (es) * 1978-07-18 1980-04-01 Hoechst Ag Procedimiento para la preparacion de nuevos derivados de 2-(4-aminopiperidino)-3,4-dihidroquinoleina.
ES482439A0 (es) * 1978-07-18 1980-04-01 Hoechst Ag Procedimiento para la preparacion de nuevos derivados de 1-(4-aminopiperidino)-3,4-dihidroisoquinoleina.
JPS5553284A (en) * 1978-10-12 1980-04-18 Yoshitomi Pharmaceut Ind Ltd Pyridazinone derivative
GB2031404A (en) * 1978-10-17 1980-04-23 Yoshitomi Pharmaceutical Pyridazinone compounds

Also Published As

Publication number Publication date
WO1982001706A1 (en) 1982-05-27
CH653684A5 (fr) 1986-01-15
DK157193C (da) 1990-04-09
ES8301967A1 (es) 1983-02-01
SE8204237L (sv) 1982-07-08
DE3152512C2 (no) 1991-01-03
SE8204237D0 (sv) 1982-07-08
AU7808581A (en) 1982-06-07
FI822471A0 (fi) 1982-07-12
FI822471L (fi) 1982-07-12
DK157193B (da) 1989-11-20
SU1215621A3 (ru) 1986-02-28
AT382376B (de) 1987-02-25
PT73959A (en) 1981-12-01
SE440653B (sv) 1985-08-12
ATA908381A (de) 1986-07-15
PT73959B (en) 1983-04-18
FI71145C (fi) 1986-11-24
IT8149680A0 (it) 1981-11-11
MX6802E (es) 1986-07-29
EP0052016B1 (en) 1984-09-05
EP0052016A1 (en) 1982-05-19
ES507545A0 (es) 1983-02-01
NO157819C (no) 1988-05-25
CA1164459A (en) 1984-03-27
US4414390A (en) 1983-11-08
KR830007644A (ko) 1983-11-04
DK307482A (da) 1982-07-08
AU547586B2 (en) 1985-10-24
PH17158A (en) 1984-06-13
FI71145B (fi) 1986-08-14
DE3152512T1 (de) 1982-11-18
NO157819B (no) 1988-02-15
KR880001657B1 (ko) 1988-09-05

Similar Documents

Publication Publication Date Title
NO822391L (no) Karbostyrilforbindelser, preparater inneholdende disse og fremgangsmaater for fremstilling av forbindelsene
DK160052C (da) Chlorsubstituerede disaccharider og fremgangsmaader til fremstilling deraf samt praeparater indeholdende sacchariderne som soedemidler
DK186981A (da) 17-substitueret-6-desoxy-7,8-dihydro-6alfa-methylnoroxymorphon samt fremgangsmaade til fremstilling deraf
NO831720L (no) Azolylmetyloksiraner, fremgangsmaate til fremstilling derav, samt fungicider inneholdende slike forbindelser
NO158561C (no) Flytende sjampo og fremgangsmaate til fremstilling derav.
DK364683A (da) Sproejte, isaer til medicinsk anvendelse
DK574581A (da) Delta2-1,2,4-triazolin-5-on-derivater og fremgangsmaade til fremstilling heraf
NO855135L (no) Modifisert polyolefin og fremgangsmaate til fremstilling derav.
NO157336C (no) Toeymyknende, flytende grovvaskemiddelblanding og fremgangsm te for fremstilling av denne.
DK409784A (da) Substituerede phenyl-alifatiske isoxaler, fremgangsmaade til fremstilling deraf samt antivirale praeparater indeholdende disse
NL8300934A (nl) Gesubstitueerde 1h-pyrazolo1,5-a-pyrimidinen, werkwijzen ter bereiding ervan, alsmede farmaceutische preparaten, die deze verbindingen bevatten.
IL62267A0 (en) Labeled antibodies,compositions containing them and methods for the use thereof
FI812810A7 (fi) Ammoniometyyliyhdisteitä, menetelmiä niiden valmistamiseksi, näitä yhdisteitä sisältäviä farmaseuttisia valvalmisteita ja viimemainittujen käyttö.
DK326484A (da) Imidazoler, fremgangsmaade til deres fremstilling og laegemidler indeholdende forbindelserne
NO853120L (no) Isfjell og fremgangsmaate for fremstilling av samme.
DK572183D0 (da) 7-carboxymethoxyphenylacetamido-3-cephemderivater,fremgangsmaade til fremstilling deraf og antibakterielle praeparater indeholdende forbindelserne
NL7902726A (nl) Sulfonato-organosilanolverbindingen en preparaten, welke deze bevatten.
NO162085C (no) Toeykondisjoneringsprodukt og fremgangsmaate til fremstilling av dette.
NO161560C (no) Symmetriske trijodisoftaldiamid-derivater og roentgenkontrastmidler inneholdende disse.
FI823910A7 (fi) Atsolyyli-penteeni- johdannaisia, menetelmiä näiden yhdisteiden valmistamiseksi sekä niitä sisältäviä bibiosidejä.
FI810025A7 (fi) Uusia bentseeniamiineja, niitä sisältäviä valmisteita ja fungisidisia menetelmiä.
DK129983A (da) 2-beta-d-ribofuranosylselenazol-4-carboxamidforbindelser og fremgangsmaader til fremstilling deraf
DK160885A (da) Benzazepinderivater, fremgangsmaade til fremstilling deraf samt praeparater indeholdende disse
DK372582A (da) Immunogent kompleks og fremgangsmaade til fremstilling deraf
FI812536A7 (fi) Uusia diaryyli-imidatsoli-yhdisteitä, menetelmiä niiden valmistamiseksi, näitä yhdisteitä sisältäviä farmasefarmaseuttisia valmisteita ja niiden käyttö.